Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholinergic neurotransmission refers to the process by which the neurotransmitter acetylcholine (ACh) is synthesized, released, and acts on its receptors to mediate communication between nerve cells or between nerves and muscles. This system is fundamental for both central and peripheral nervous system functions, including voluntary muscle movement, autonomic regulation, memory, attention, arousal, and learning. Key components include the synthesis of ACh from choline and acetyl CoA by choline acetyltransferase (ChAT), storage in synaptic vesicles, release upon Ca²⁺ influx, binding to nicotinic or muscarinic receptors, and termination of the signal by acetylcholinesterase (AChE). Dysfunction in this pathway is associated with diseases such as Alzheimer’s disease and Myasthenia gravis.
Varies depending on the specific drug and target within the pathway (e.g., cholinesterase inhibition, muscarinic receptor antagonism).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholinergic Neurotransmission (N/A).